Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily single-strength vs thrice-weekly double-strength trimethoprim/sulfamethoxazole for Pneumocystis prophylaxis in solid organ transplant recipients
TCTR20220720010Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in pneumocystis pneumonia (PCP), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Jul 2023; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on TCTR20220720010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220720010.